JP2024540062A5 - - Google Patents
Info
- Publication number
- JP2024540062A5 JP2024540062A5 JP2024525253A JP2024525253A JP2024540062A5 JP 2024540062 A5 JP2024540062 A5 JP 2024540062A5 JP 2024525253 A JP2024525253 A JP 2024525253A JP 2024525253 A JP2024525253 A JP 2024525253A JP 2024540062 A5 JP2024540062 A5 JP 2024540062A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111307619.3 | 2021-11-05 | ||
| CN202111307619 | 2021-11-05 | ||
| PCT/CN2022/129834 WO2023078386A1 (zh) | 2021-11-05 | 2022-11-04 | 抗cldn18.2抗体及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540062A JP2024540062A (ja) | 2024-10-31 |
| JP2024540062A5 true JP2024540062A5 (https=) | 2026-01-28 |
Family
ID=86240666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525253A Pending JP2024540062A (ja) | 2021-11-05 | 2022-11-04 | 抗ｃｌｄｎ１８．２抗体及びその用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240409629A1 (https=) |
| EP (1) | EP4428154A4 (https=) |
| JP (1) | JP2024540062A (https=) |
| KR (1) | KR20240099289A (https=) |
| CN (1) | CN118139888A (https=) |
| TW (1) | TW202323285A (https=) |
| WO (1) | WO2023078386A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024114667A1 (zh) * | 2022-11-30 | 2024-06-06 | 正大天晴药业集团股份有限公司 | 抗cldn18.2抗体药物偶联物及其药物组合物和用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD120303A1 (https=) | 1975-05-15 | 1976-06-05 | ||
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| EP0983303B1 (en) | 1997-05-21 | 2006-03-08 | Biovation Limited | Method for the production of non-immunogenic proteins |
| WO2013174403A1 (en) * | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2013174404A1 (en) * | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| WO2016165762A1 (en) * | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| ES2979068T3 (es) * | 2016-07-08 | 2024-09-24 | Crage Medical Co Ltd | Anticuerpos para anti-claudina 18A2 y utilización de los mismos |
| JP2021523090A (ja) * | 2018-03-09 | 2021-09-02 | 科済生物医薬（上海）有限公司Ｃａｒｓｇｅｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｃｏ．，Ｌｔｄ． | 腫瘍を治療するための方法および組成物 |
| WO2019242505A1 (zh) * | 2018-06-17 | 2019-12-26 | 上海健信生物医药科技有限公司 | 靶向cldn18.2的抗体、双特异性抗体、adc和car及其应用 |
| KR20210050547A (ko) * | 2018-08-27 | 2021-05-07 | 난징 산홈 팔마세우티칼 컴퍼니 리미티드 | 항-클라우딘18.2 항체 및 이의 용도 |
| JP2022511394A (ja) * | 2018-09-30 | 2022-01-31 | カファ セラピューティクス リミテッド | Ｃｌｄｎ１８の抗体及び化学療法薬の併用療法 |
| EP3872093A4 (en) * | 2018-10-22 | 2022-10-19 | Shanghai Genbase Biotechnology Co., Ltd. | ANTI-CLDN18.2 ANTIBODIES AND USES THEREOF |
| BR112021011014A2 (pt) * | 2018-12-07 | 2021-08-31 | Zlip Holding Limited | Anticorpos anti-claudina e usos destes |
| EP3902824A4 (en) * | 2018-12-28 | 2023-01-04 | Sparx Therapeutics Inc. | FOR CLAUDIN 18.2 SPECIFIC BINDING MOLECULES, COMPOSITIONS AND METHODS OF TREATMENT OF CANCER AND OTHER DISEASES |
| CN109762067B (zh) * | 2019-01-17 | 2020-02-28 | 北京天广实生物技术股份有限公司 | 结合人Claudin 18.2的抗体及其用途 |
| EP3960766A4 (en) | 2019-04-19 | 2022-12-07 | Keymed Biosciences Co.,Ltd. | ANTI-TUMOR THERAPEUTIC AGENT AND USE THEREOF |
| CN114206935B (zh) * | 2019-05-24 | 2024-01-12 | 三优生物医药(上海)有限公司 | 新型cldn18.2结合分子 |
| KR102777693B1 (ko) * | 2019-07-17 | 2025-03-07 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Claudin18 항체 및 암 치료 방법 |
| JP7767270B2 (ja) * | 2019-08-20 | 2025-11-11 | スーチョウ トランセンタ セラピューティクス カンパニー，リミテッド | 新規抗ｃｌｄｎ１８．２抗体 |
| CN112480248B (zh) * | 2020-11-24 | 2023-05-05 | 三优生物医药(上海)有限公司 | 与cld18a2特异性结合的分子 |
| CN113416260B (zh) * | 2021-04-14 | 2022-02-01 | 南京凯地医疗技术有限公司 | 靶向Claudin18.2的特异性嵌合抗原受体细胞及其制备方法和应用 |
-
2022
- 2022-11-04 JP JP2024525253A patent/JP2024540062A/ja active Pending
- 2022-11-04 EP EP22889407.7A patent/EP4428154A4/en active Pending
- 2022-11-04 US US18/704,659 patent/US20240409629A1/en active Pending
- 2022-11-04 KR KR1020247016174A patent/KR20240099289A/ko active Pending
- 2022-11-04 WO PCT/CN2022/129834 patent/WO2023078386A1/zh not_active Ceased
- 2022-11-04 TW TW111142259A patent/TW202323285A/zh unknown
- 2022-11-04 CN CN202280072576.1A patent/CN118139888A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022515318A5 (https=) | ||
| JP2021514664A5 (https=) | ||
| JP2022516505A (ja) | 癌および他の疾患の治療のための、クローディン１８．２に特異的な結合分子、その組成物および方法 | |
| JP2019535250A5 (https=) | ||
| JP2019519492A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| CN111278861A (zh) | Pd-l1抗体、其抗原结合片段及医药用途 | |
| JP2024016024A5 (https=) | ||
| JP2022512891A5 (https=) | ||
| JP2022512642A5 (https=) | ||
| JP2022550243A5 (https=) | ||
| JP2022532991A5 (https=) | ||
| TW202115121A (zh) | 抗ｐｄ－ｌ１抗體及其應用 | |
| JP2022521305A (ja) | 抗ｐｄ－ｌ１抗体及びその使用 | |
| JP2023545521A5 (https=) | ||
| JP2024535930A5 (https=) | ||
| JP2025507938A (ja) | 抗ｐｄ－ｌ２抗体 | |
| CN114790241B (zh) | 抗tigit抗体及其应用 | |
| JP2025513745A5 (https=) | ||
| RU2019116638A (ru) | Биспецифические полипептиды к gitr и ctla-4 | |
| JP2025503229A5 (https=) | ||
| JP2024540062A5 (https=) | ||
| JP2022502079A5 (https=) | ||
| EP4534562A1 (en) | Bispecific antibody and application thereof | |
| JP7811028B2 (ja) | ヒトｃｘｃｌ１６抗体およびその使用 |